Celyad Oncology SA (FRA:1C0)
0.1315
-0.0010 (-0.75%)
Last updated: Jan 28, 2026, 2:51 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €7.83 million as of January 30, 2026. Its market cap has decreased by -61.13% in one year.
Market Cap
7.83M
Enterprise Value
7.87M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.13
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 7.83M, a decrease of -92.32%. That is a compound annual growth rate of -18.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 7.83M | 2.94% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erlebnis Akademie AG | 10.45M |
| Beyond Frames Entertainment AB | 9.95M |
| plenum AG | 9.51M |
| DCI Database for Commerce and Industry AG | 9.49M |
| Turbon AG | 8.94M |
| AHT Syngas Technology | 8.94M |
| MedNation AG | 8.70M |
| Bio-Gate AG | 7.54M |